Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEPOD Paracetamol Detection Validation
NCT04690673Completed
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial. Primary endpoint: Comparison of Geometric Means of Cmax and AUC 0-last of Paracetamol Measured by the Novel Electrochemical Method With Mass-spectrometry in Capillary Whole Blood Samples at 1 day. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04690673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690673.